Marlio Charles Mosseri

Marlio Charles Mosseri appears in our data through filings on Nuvectis Pharma, Inc. shares, published by SEC (Form 4). We count 45 filings; the first trade dates from 15 June 2023 and the latest from 27 October 2025.

On the market, this insider has only ever bought: 45 purchases, €6.4M in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2025: 22 purchases and no sales on the market.

Half of the purchases are above €76k and half below. Of 43 purchases, 22 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Looking at 7 purchases old enough to measure, the stock rose over the following 90 days in 29% of cases; the median change was -22.5%. They describe history only and say nothing certain about the share price ahead.

Most recently, on 29 October 2025, the filings show an open-market purchase worth €185k in Nuvectis Pharma, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.